Invention Grant
- Patent Title: Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers
-
Application No.: US14769504Application Date: 2014-02-26
-
Publication No.: US10398661B2Publication Date: 2019-09-03
- Inventor: Pothana Saikumar , Prajjal Kanti Singha
- Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2014/018709 WO 20140226
- International Announcement: WO2014/134179 WO 20140904
- Main IPC: G01N33/574
- IPC: G01N33/574 ; A61K31/19 ; A61K45/06 ; C12N15/113 ; C12Q1/6886 ; A61K39/00
Abstract:
The invention provides methods for classifying a cancer as susceptible to transmembrane prostate androgen induced (TMEPAI)-directed therapies, and methods for treating such cancers. The field of the invention pertains generally to medicine, pathology and oncology. More particularly, it addresses the treatment of breast cancer, such as triple-negative breast cancer, using a transmembrane prostate androgen induced (TMEPAI)-directed therapy.
Public/Granted literature
- US20160000735A1 METHODS FOR CLASSIFYING A CANCER AS SUSCEPTIBLE TO TMEPAI-DIRECTED THERAPIES AND TREATING SUCH CANCERS Public/Granted day:2016-01-07
Information query
IPC分类:
